Investment
Features
FeesSafety
Academy
More
Pluang+

Law firm probes Evolus over FDA warning on misleading Jeuveau ad, shares drop 7%

Market News
20 Oct 2026
GlobeNewsWire
View Source
Bearish
Law firm probes Evolus over FDA warning on misleading Jeuveau ad, shares drop 7%

Pomerantz LLP is investigating claims against Evolus, Inc. following an FDA warning about false and misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the ad for downplaying safety risks and making exaggerated claims about the product's effectiveness. After the warning was disclosed on October 2, 2026, Evolus's stock fell 7.15% to $7.14 per share. The investigation may lead to a class action lawsuit if securities fraud or unlawful practices are confirmed.

Evolus, Inc. is the subject of an investor investigation following an FDA warning. For readers following the health sector, here is Pluang's market snapshot as of Oct 21, 2026 03:11 WIB: Out of 150 priced US health stocks, 124 rose and 26 fell. Notable movers include ISRG at USD 390.00 with a -9.97% change and balanced Pluang order activity, RLAY at USD 18.55 up 8.54%, and SYRE at USD 91.40 up 7.88%.

More News

Medical Informatics Corp. opens Sickbay Demo Center at Texas Medical Center to enhance patient care with real-time data integration.

Medical Informatics Corp. opens Sickbay Demo Center at Texas Medical Center to enhance patient care with real-time data integration.

Medical Informatics Corp. has launched the Sickbay Experience Demo Center at Texas Medical Center's Helix Park, showcasing its FDA-cleared Sickbay platform. This interactive center demonstrates how real-time patient data from various medical devices ...

Others
Bullish
2 hours ago
Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico Q3 earnings miss estimates despite revenue and EBITDA growth.

Grupo Aeroportuario del Pacífico reported Q3 2026 earnings per share of $2.66 and revenue of $632.9 million, both below analyst expectations. Despite the miss, the company saw a 13.2% rise in revenue excluding construction services and a 19.2% increa...

Company Fundamentals
Neutral
3 hours ago
Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust Q3 2026 earnings expected to rise on higher interest and fee income.

Northern Trust is set to report its Q3 2026 earnings with analysts forecasting a 24.9% rise in earnings per share to $2.86 and an 11.8% increase in revenue to $2.26 billion. Growth is driven by an 11.4% increase in net interest income and a 12.1% ris...

Company Fundamentals
Bullish
3 hours ago
Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's Q3 2026 earnings preview highlights credit ratings and AI-driven analytics growth.

Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...

Company Fundamentals
Neutral
4 hours ago
Collector Crypt tops 24-hour revenue, surpassing Hyperliquid and Papertrade on Solana platform

Collector Crypt tops 24-hour revenue, surpassing Hyperliquid and Papertrade on Solana platform

Collector Crypt, a Solana-based marketplace that tokenizes physical trading cards, has surpassed both Hyperliquid and Papertrade in 24-hour revenue, reaching over $532,550. This signals a shift in the crypto market towards tokenized collectibles rath...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App